Is representation enough or should we be targeting equitable inclusion?

To achieve health equity, we advocate for the overrepresentation of particular racial and ethnic minority groups so that analyses of group-specific treatment effects can be optimally powered. A paradigm shift is needed across multiple stakeholders, as well as in the engagement of community programmes, the role of investigators from racial and ethnic minority backgrounds and clinical trial regulations.

Automated summary

A paradigm shift is needed across various aspects, including stakeholders, community engagement, investigators from racial and ethnic minority backgrounds, and clinical trial regulations, to achieve health equity.